ModernaTX IL12 Polypeptide Patent EP3625246A1
Summary
The EPO published patent application EP3625246A1 for polynucleotides encoding tethered interleukin-12 (IL12) polypeptides, filed by ModernaTX, Inc. The application names Ankita Mishra, Joshua Frederick, and Sushma Gurumurthy as inventors, with IPC classifications C07K 14/54 and A61K 38/20. The publication covers 35 designated contracting and extension states including major European markets. Pharmaceutical and biotechnology companies developing interleukin-based therapeutics should review this publication for potential freedom-to-operate implications in the European market.
About this source
GovPing monitors EPO Patent Bulletin - Pharma (A61K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 72 changes logged to date.
What changed
The EPO published patent application EP3625246A1 filed by ModernaTX, Inc. covering polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and their therapeutic uses. The application designates 35 European states including major markets such as Germany, France, the United Kingdom, Italy, and Spain.
Pharmaceutical and biotechnology companies engaged in IL-12 or interleukin-based therapeutic development should review this publication for potential freedom-to-operate concerns in European markets. Competitors with overlapping patent portfolios may need to assess design-around options or consider licensing discussions.
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
POLYNUCLEOTIDES ENCODING TETHERED INTERLEUKIN-12 (IL12) POLYPEPTIDES AND USES THEREOF
Publication EP3625246A1 Kind: A1 Apr 15, 2026
Applicants
ModernaTX, Inc.
Inventors
MISHRA, Ankita, FREDERICK, Joshua, GURUMURTHY, Sushma
IPC Classifications
C07K 14/54 20060101AFI20181123BHEP A61K 38/20 20060101ALI20181123BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.